In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.

• Expanding access to advanced testing (00:32): Discover how a new collaboration with Pathology Asia Holdings will expand access to molecular and genomic testing.
• Advancing DNA mutation detection (04:50): Hear about research to detect DNA mutations across the genome and its potential implications for clinical diagnostics.
• Innovating in autoimmune neurology (07:39): Learn how the unique dynamics of the Mayo Clinic Neuroimmunology Laboratory help drive innovation.

Resources

• Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions
• Autoimmune neurology: At the forefront of a testing evolution
• Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine
• Somatic mutations: Study advances DNA detection

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the future of diagnostics. Later, Eric Hsi, M.D., chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, shares how the department is advancing innovation and helping transform healthcare through laboratory medicine.

• Trends shaping the future of diagnostics (00:31): Dr. Morice discusses the scientific advances, emerging technologies, and evolving patient expectations that are shaping the future of clinical diagnostics.
• Laboratory transformation and innovation at Mayo Clinic (08:20): Dr. Hsi discusses his perspective on laboratory medicine's role in healthcare transformation and how his team approaches innovation across Mayo Clinic.
• Hematopathology advances (18:08): As a leader in hematopathology, Dr. Hsi shares the advances he is most excited about for their ability to improve patient care.

Resources

• ”Answers From the Lab” podcast: Get to Know the DLMP Chair: Eric Hsi, M.D.
• Dr. Bill Morice explores trends transforming diagnostics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Mayo Clinic’s new collaboration with Thermo Fisher and the latest on the Protecting Access to Medicare Act (PAMA). Later, Dr. Pritt welcomes Matt Binnicker, Ph.D., Mayo Clinic Laboratories’ chief scientific officer and a leader in novel diagnostics for viral infections, to explore seasonal virus activity.

• Mayo Clinic and Thermo Fisher collaboration (00:29): Explore how this initiative is turning early biological signals into opportunities for prevention, diagnosis, and treatment.
• PAMA preliminary rates (04:20): Get an overview of CMS's preliminary 2027 Medicare Clinical Laboratory Fee Schedule based on data collected through PAMA.
• Virus update and outlook (08:30): Learn what experts are predicting for seasonal viruses this winter.
• Testing stewardship and innovation (15:43): Discover guidance for seasonal virus testing and how new advances are improving detection.

Resources

• Mayo Clinic News Network: Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear
• CMS: Preliminary Calendar Year (CY) 2027 Medicare Clinical Laboratory Fee Schedule Payment Rates
• Respiratory viruses: Testing for early detection